Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/19/25 17:54 | 5/15/25 | DAWN | Health | Drug | Pharmaceutical Preparations | Merendino Lauren | CA | O | Chief Co | 2 | M.d | 25 | 1.70 | 0 | 14 | 70 | 35 | D | ||||||||||||||
5/19/25 17:54 | 5/16/25 | DAWN | Health | Drug | Pharmaceutical Preparations | Merendino Lauren | CA | O | Chief Co | 2 | S.d | -25 | 1.70 | 0 | -14 | 35 | D | |||||||||||||||
5/19/25 17:48 | 5/15/25 | DAWN | Health | Drug | Pharmaceutical Preparations | Dubow Adam | CA | O | GC | 2 | M.d | 28 | 1.71 | 0 | 17 | 55 | 47 | D | ||||||||||||||
5/19/25 17:48 | 5/16/25 | DAWN | Health | Drug | Pharmaceutical Preparations | Dubow Adam | CA | O | GC | 2 | S.d | -28 | 1.71 | 0 | -17 | 47 | D | |||||||||||||||
5/19/25 17:45 | 5/15/25 | DAWN | Health | Drug | Pharmaceutical Preparations | York Charles N II | CA | O | COO,CFO, | 2 | M.d | 27 | 1.27 | 0 | 21 | 9 | 265 | D | ||||||||||||||
5/19/25 17:45 | 5/16/25 | DAWN | Health | Drug | Pharmaceutical Preparations | York Charles N II | CA | O | COO,CFO, | 2 | S.d | -27 | 1.27 | 0 | -21 | 265 | D | |||||||||||||||
5/19/25 17:44 | 5/15/25 | DAWN | Health | Drug | Pharmaceutical Preparations | Bender Jeremy | CA | DO | CEO | 2 | M.d | 87 | 1.91 | 0 | 46 | 3 | 1,755 | D | ||||||||||||||
5/19/25 17:44 | 5/16/25 | DAWN | Health | Drug | Pharmaceutical Preparations | Bender Jeremy | CA | DO | CEO | 2 | S.d | -87 | 1.91 | 0 | -46 | 1,755 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |